Following order passed by the Customs & Central Excise Settlement Commission
Astec Lifesciences announced that the Company has received an order dated 22 June 2015 passed by the Customs & Central Excise Settlement Commission on a settlement application filed by the Company in an excise matter pertaining to the Company's Export Oriented Unit at B-17, MIDC, Mahad. The order, inter alia, requires the Company to pay an amount of Rs 93.69 lakh towards excise duty and penalty (excluding applicable interest thereon) in addition to an amount of Rs. 16.93 crores already paid by the Company upto the date of order and accounted for in the financial year 2014-15.Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app